Sunbelt Securities Inc. Buys 382 Shares of The Clorox Company (NYSE:CLX)

Sunbelt Securities Inc. increased its stake in shares of The Clorox Company (NYSE:CLXFree Report) by 19.4% during the first quarter, according to the company in its most recent filing with the SEC. The fund owned 2,355 shares of the company’s stock after acquiring an additional 382 shares during the period. Sunbelt Securities Inc.’s holdings in Clorox were worth $361,000 as of its most recent filing with the SEC.

A number of other institutional investors have also made changes to their positions in CLX. Eagle Rock Investment Company LLC lifted its position in Clorox by 8.0% during the 1st quarter. Eagle Rock Investment Company LLC now owns 22,263 shares of the company’s stock worth $3,409,000 after acquiring an additional 1,645 shares during the last quarter. Retirement Planning Group LLC boosted its stake in shares of Clorox by 4.2% in the 1st quarter. Retirement Planning Group LLC now owns 2,325 shares of the company’s stock valued at $356,000 after purchasing an additional 94 shares in the last quarter. Riverview Trust Co acquired a new stake in shares of Clorox during the first quarter worth approximately $43,000. Global Assets Advisory LLC acquired a new position in Clorox in the first quarter worth $8,963,000. Finally, Game Plan Financial Advisors LLC bought a new stake in Clorox during the 1st quarter worth about $1,025,000. 78.53% of the stock is owned by institutional investors.

Clorox Price Performance

Shares of NYSE:CLX opened at $136.55 on Friday. The company has a 50 day moving average of $137.23 and a 200 day moving average of $143.86. The stock has a market cap of $16.96 billion, a P/E ratio of 70.75, a P/E/G ratio of 2.15 and a beta of 0.39. The company has a current ratio of 0.90, a quick ratio of 0.53 and a debt-to-equity ratio of 9.73. The Clorox Company has a 12 month low of $114.68 and a 12 month high of $169.14.

Clorox (NYSE:CLXGet Free Report) last released its quarterly earnings results on Tuesday, April 30th. The company reported $1.71 earnings per share for the quarter, beating analysts’ consensus estimates of $1.33 by $0.38. Clorox had a return on equity of 302.49% and a net margin of 3.33%. The business had revenue of $1.81 billion for the quarter, compared to the consensus estimate of $1.87 billion. During the same quarter last year, the business posted $1.51 earnings per share. The company’s revenue for the quarter was down 5.3% on a year-over-year basis. As a group, sell-side analysts forecast that The Clorox Company will post 5.91 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several brokerages have weighed in on CLX. Wells Fargo & Company dropped their price objective on Clorox from $140.00 to $135.00 and set an “underweight” rating for the company in a report on Thursday, May 2nd. JPMorgan Chase & Co. dropped their price target on Clorox from $159.00 to $158.00 and set a “neutral” rating on the stock in a research note on Wednesday, May 1st. Deutsche Bank Aktiengesellschaft reduced their target price on shares of Clorox from $155.00 to $151.00 and set a “hold” rating for the company in a report on Wednesday, April 17th. Jefferies Financial Group raised Clorox from an “underperform” rating to a “hold” rating and set a $145.00 price target on the stock in a research report on Tuesday, March 26th. Finally, Evercore ISI dropped their target price on shares of Clorox from $145.00 to $142.00 and set an “underperform” rating on the stock in a report on Wednesday, May 1st. Five research analysts have rated the stock with a sell rating and fourteen have issued a hold rating to the company. Based on data from MarketBeat, Clorox currently has an average rating of “Hold” and a consensus price target of $145.33.

Check Out Our Latest Stock Analysis on Clorox

About Clorox

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Featured Articles

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.